Group One Trading
SGMT icon

Group One Trading’s Sagimet Biosciences SGMT Stock Holding History

Group One Trading’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$175K Sell
22,600
-600
-3% -$4.08K ﹤0.01% 4393
2026
Q1 		$121K Buy
23,200
+14,800
+176% +$82.5K ﹤0.01% 4559
2025
Q4 		$49.7K Buy
8,400
+5,600
+200% +$40.2K ﹤0.01% 5609
2025
Q3 		$19.2K Buy
2,800
+1,400
+100% +$11.4K ﹤0.01% 6719
2025
Q2 		$10.7K Sell
1,400
-8,000
-85% -$33.8K ﹤0.01% 6680
2025
Q1 		$30.6K Buy
9,400
+2,600
+38% +$10.9K ﹤0.01% 5527
2024
Q4 		$30.6K Buy
6,800
+3,800
+127% +$19.3K ﹤0.01% 5419
2024
Q3 		$8.31K Buy
+3,000
New +$9.25K ﹤0.01% 5687

Other funds holding SGMT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return

Group One Trading's SGMT Position: Q2 2026 in Review

Group One Trading sold out of Sagimet Biosciences (SGMT) in Q2 2026, closing a stake of 13,061 shares — an estimated $88.8K sold.

Group One Trading first reported a position in SGMT in Q3 2024 and held it in 2 quarters. The position peaked at $68.2K in Q1 2026. 122 funds tracked by Wall St. Rank hold SGMT as of Q2 2026.

  • Group One Trading reported no remaining Sagimet Biosciences position as of Q2 2026 after selling out during the quarter.
  • Group One Trading sold 13,061 Sagimet Biosciences shares in Q2 2026, an estimated $88.8K.
  • Group One Trading first reported a position in Sagimet Biosciences in Q3 2024 and held it in 2 quarters.
  • Group One Trading's Sagimet Biosciences position peaked at $68.2K in Q1 2026.
  • 122 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.